lepr db Search Results


leptin receptor lepr antagonist  (MedChemExpress)
93
MedChemExpress leptin receptor lepr antagonist
Leptin Receptor Lepr Antagonist, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/leptin receptor lepr antagonist/product/MedChemExpress
Average 93 stars, based on 1 article reviews
leptin receptor lepr antagonist - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
lepr  (Proteintech)
94
Proteintech lepr
Lepr, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lepr/product/Proteintech
Average 94 stars, based on 1 article reviews
lepr - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
rabbit polyclonal anti lepr antibody  (Boster Bio)
93
Boster Bio rabbit polyclonal anti lepr antibody
Rabbit Polyclonal Anti Lepr Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal anti lepr antibody/product/Boster Bio
Average 93 stars, based on 1 article reviews
rabbit polyclonal anti lepr antibody - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
lepr expression plasmid  (OriGene)
90
OriGene lepr expression plasmid
Hypothalamic leptin receptor knockdown attenuates the adipose redistribution-associated with unilateral iWAT injection of Rec2-Cre in male PTEN flox mice. (A) Experimental design. (B) Hypothalamic <t>Lepr</t> <t>expression.</t> (C) iWAT weight at sacrifice. (D) Ratio of Rec2-treated iWAT to the untreated contralateral iWAT. (E) Relative mRNA expression of leptin in iWAT. (F) Ratio of leptin mRNA between Rec2-treated iWAT and untreated contralateral iWAT. Data are means ± SEM. n = 6–7 per group for body weight and tissue weight data. n = 4–6 for qPCR data. *P < 0.05, **P < 0.01, ***P < 0.001.
Lepr Expression Plasmid, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lepr expression plasmid/product/OriGene
Average 90 stars, based on 1 article reviews
lepr expression plasmid - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
mouse leptin receptor picokine elisa kit  (Boster Bio)
93
Boster Bio mouse leptin receptor picokine elisa kit
PYY(3 – 36) and Ex4 in combination increases <t>leptin</t> sensitivity and increases the concentration of circulating soluble leptin receptor. A-D) Accumulated food intake (kcal) and body weight change (g) 4h (A, B) and 20h (C, D) after leptin injection(5 mg/kg) at treatment day 10.E) Plasma leptin concentration (pM) at day 15, F: Plasma concentration of soluble leptin receptor (SLR) at day 15, and G: Hepatic Lepra expression at day 15. Data are expressed as means ± SEM, n = 12. Statistical significance was assessed by one-way ANOVA (E) or by two-way ANOVA followed (F and G). In both cases, ANOVA test's were followed Tukey's multiple comparisons test. In case of A-D, test of significance was restricted to comparing within group effects (vehicle and leptin treatment). *p < 0.05, **p < 0.01, and ***p < 0.001.
Mouse Leptin Receptor Picokine Elisa Kit, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse leptin receptor picokine elisa kit/product/Boster Bio
Average 93 stars, based on 1 article reviews
mouse leptin receptor picokine elisa kit - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
bks ++lepr db  (Harlan Laboratories)
90
Harlan Laboratories bks ++lepr db
PYY(3 – 36) and Ex4 in combination increases <t>leptin</t> sensitivity and increases the concentration of circulating soluble leptin receptor. A-D) Accumulated food intake (kcal) and body weight change (g) 4h (A, B) and 20h (C, D) after leptin injection(5 mg/kg) at treatment day 10.E) Plasma leptin concentration (pM) at day 15, F: Plasma concentration of soluble leptin receptor (SLR) at day 15, and G: Hepatic Lepra expression at day 15. Data are expressed as means ± SEM, n = 12. Statistical significance was assessed by one-way ANOVA (E) or by two-way ANOVA followed (F and G). In both cases, ANOVA test's were followed Tukey's multiple comparisons test. In case of A-D, test of significance was restricted to comparing within group effects (vehicle and leptin treatment). *p < 0.05, **p < 0.01, and ***p < 0.001.
Bks ++Lepr Db, supplied by Harlan Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bks ++lepr db/product/Harlan Laboratories
Average 90 stars, based on 1 article reviews
bks ++lepr db - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
non-diabetic lepr db /+ ( db /+) male littermates  (clea japan inc)
90
clea japan inc non-diabetic lepr db /+ ( db /+) male littermates
PYY(3 – 36) and Ex4 in combination increases <t>leptin</t> sensitivity and increases the concentration of circulating soluble leptin receptor. A-D) Accumulated food intake (kcal) and body weight change (g) 4h (A, B) and 20h (C, D) after leptin injection(5 mg/kg) at treatment day 10.E) Plasma leptin concentration (pM) at day 15, F: Plasma concentration of soluble leptin receptor (SLR) at day 15, and G: Hepatic Lepra expression at day 15. Data are expressed as means ± SEM, n = 12. Statistical significance was assessed by one-way ANOVA (E) or by two-way ANOVA followed (F and G). In both cases, ANOVA test's were followed Tukey's multiple comparisons test. In case of A-D, test of significance was restricted to comparing within group effects (vehicle and leptin treatment). *p < 0.05, **p < 0.01, and ***p < 0.001.
Non Diabetic Lepr Db /+ ( Db /+) Male Littermates, supplied by clea japan inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-diabetic lepr db /+ ( db /+) male littermates/product/clea japan inc
Average 90 stars, based on 1 article reviews
non-diabetic lepr db /+ ( db /+) male littermates - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
leptin receptor (lepr) gene mutant ( db / db ) mice  (GemPharmatech Co Ltd)
90
GemPharmatech Co Ltd leptin receptor (lepr) gene mutant ( db / db ) mice
PYY(3 – 36) and Ex4 in combination increases <t>leptin</t> sensitivity and increases the concentration of circulating soluble leptin receptor. A-D) Accumulated food intake (kcal) and body weight change (g) 4h (A, B) and 20h (C, D) after leptin injection(5 mg/kg) at treatment day 10.E) Plasma leptin concentration (pM) at day 15, F: Plasma concentration of soluble leptin receptor (SLR) at day 15, and G: Hepatic Lepra expression at day 15. Data are expressed as means ± SEM, n = 12. Statistical significance was assessed by one-way ANOVA (E) or by two-way ANOVA followed (F and G). In both cases, ANOVA test's were followed Tukey's multiple comparisons test. In case of A-D, test of significance was restricted to comparing within group effects (vehicle and leptin treatment). *p < 0.05, **p < 0.01, and ***p < 0.001.
Leptin Receptor (Lepr) Gene Mutant ( Db / Db ) Mice, supplied by GemPharmatech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/leptin receptor (lepr) gene mutant ( db / db ) mice/product/GemPharmatech Co Ltd
Average 90 stars, based on 1 article reviews
leptin receptor (lepr) gene mutant ( db / db ) mice - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
bks.cg-+lepr db /+lepr db /olahsd mice  (Harlan UK Ltd)
90
Harlan UK Ltd bks.cg-+lepr db /+lepr db /olahsd mice
PYY(3 – 36) and Ex4 in combination increases <t>leptin</t> sensitivity and increases the concentration of circulating soluble leptin receptor. A-D) Accumulated food intake (kcal) and body weight change (g) 4h (A, B) and 20h (C, D) after leptin injection(5 mg/kg) at treatment day 10.E) Plasma leptin concentration (pM) at day 15, F: Plasma concentration of soluble leptin receptor (SLR) at day 15, and G: Hepatic Lepra expression at day 15. Data are expressed as means ± SEM, n = 12. Statistical significance was assessed by one-way ANOVA (E) or by two-way ANOVA followed (F and G). In both cases, ANOVA test's were followed Tukey's multiple comparisons test. In case of A-D, test of significance was restricted to comparing within group effects (vehicle and leptin treatment). *p < 0.05, **p < 0.01, and ***p < 0.001.
Bks.Cg +Lepr Db /+Lepr Db /Olahsd Mice, supplied by Harlan UK Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bks.cg-+lepr db /+lepr db /olahsd mice/product/Harlan UK Ltd
Average 90 stars, based on 1 article reviews
bks.cg-+lepr db /+lepr db /olahsd mice - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
lepr db/+ mice  (AgResearch)
90
AgResearch lepr db/+ mice
PYY(3 – 36) and Ex4 in combination increases <t>leptin</t> sensitivity and increases the concentration of circulating soluble leptin receptor. A-D) Accumulated food intake (kcal) and body weight change (g) 4h (A, B) and 20h (C, D) after leptin injection(5 mg/kg) at treatment day 10.E) Plasma leptin concentration (pM) at day 15, F: Plasma concentration of soluble leptin receptor (SLR) at day 15, and G: Hepatic Lepra expression at day 15. Data are expressed as means ± SEM, n = 12. Statistical significance was assessed by one-way ANOVA (E) or by two-way ANOVA followed (F and G). In both cases, ANOVA test's were followed Tukey's multiple comparisons test. In case of A-D, test of significance was restricted to comparing within group effects (vehicle and leptin treatment). *p < 0.05, **p < 0.01, and ***p < 0.001.
Lepr Db/+ Mice, supplied by AgResearch, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lepr db/+ mice/product/AgResearch
Average 90 stars, based on 1 article reviews
lepr db/+ mice - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
db / db ( lepr +/− ) mice  (clea japan inc)
90
clea japan inc db / db ( lepr +/− ) mice
PYY(3 – 36) and Ex4 in combination increases <t>leptin</t> sensitivity and increases the concentration of circulating soluble leptin receptor. A-D) Accumulated food intake (kcal) and body weight change (g) 4h (A, B) and 20h (C, D) after leptin injection(5 mg/kg) at treatment day 10.E) Plasma leptin concentration (pM) at day 15, F: Plasma concentration of soluble leptin receptor (SLR) at day 15, and G: Hepatic Lepra expression at day 15. Data are expressed as means ± SEM, n = 12. Statistical significance was assessed by one-way ANOVA (E) or by two-way ANOVA followed (F and G). In both cases, ANOVA test's were followed Tukey's multiple comparisons test. In case of A-D, test of significance was restricted to comparing within group effects (vehicle and leptin treatment). *p < 0.05, **p < 0.01, and ***p < 0.001.
Db / Db ( Lepr +/− ) Mice, supplied by clea japan inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/db / db ( lepr +/− ) mice/product/clea japan inc
Average 90 stars, based on 1 article reviews
db / db ( lepr +/− ) mice - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
bks (d)- lepr db /j  (Syagen Technology Inc)
90
Syagen Technology Inc bks (d)- lepr db /j
PYY(3 – 36) and Ex4 in combination increases <t>leptin</t> sensitivity and increases the concentration of circulating soluble leptin receptor. A-D) Accumulated food intake (kcal) and body weight change (g) 4h (A, B) and 20h (C, D) after leptin injection(5 mg/kg) at treatment day 10.E) Plasma leptin concentration (pM) at day 15, F: Plasma concentration of soluble leptin receptor (SLR) at day 15, and G: Hepatic Lepra expression at day 15. Data are expressed as means ± SEM, n = 12. Statistical significance was assessed by one-way ANOVA (E) or by two-way ANOVA followed (F and G). In both cases, ANOVA test's were followed Tukey's multiple comparisons test. In case of A-D, test of significance was restricted to comparing within group effects (vehicle and leptin treatment). *p < 0.05, **p < 0.01, and ***p < 0.001.
Bks (D) Lepr Db /J, supplied by Syagen Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bks (d)- lepr db /j/product/Syagen Technology Inc
Average 90 stars, based on 1 article reviews
bks (d)- lepr db /j - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Hypothalamic leptin receptor knockdown attenuates the adipose redistribution-associated with unilateral iWAT injection of Rec2-Cre in male PTEN flox mice. (A) Experimental design. (B) Hypothalamic Lepr expression. (C) iWAT weight at sacrifice. (D) Ratio of Rec2-treated iWAT to the untreated contralateral iWAT. (E) Relative mRNA expression of leptin in iWAT. (F) Ratio of leptin mRNA between Rec2-treated iWAT and untreated contralateral iWAT. Data are means ± SEM. n = 6–7 per group for body weight and tissue weight data. n = 4–6 for qPCR data. *P < 0.05, **P < 0.01, ***P < 0.001.

Journal: Molecular Metabolism

Article Title: Adipose PTEN regulates adult adipose tissue homeostasis and redistribution via a PTEN-leptin-sympathetic loop

doi: 10.1016/j.molmet.2019.09.008

Figure Lengend Snippet: Hypothalamic leptin receptor knockdown attenuates the adipose redistribution-associated with unilateral iWAT injection of Rec2-Cre in male PTEN flox mice. (A) Experimental design. (B) Hypothalamic Lepr expression. (C) iWAT weight at sacrifice. (D) Ratio of Rec2-treated iWAT to the untreated contralateral iWAT. (E) Relative mRNA expression of leptin in iWAT. (F) Ratio of leptin mRNA between Rec2-treated iWAT and untreated contralateral iWAT. Data are means ± SEM. n = 6–7 per group for body weight and tissue weight data. n = 4–6 for qPCR data. *P < 0.05, **P < 0.01, ***P < 0.001.

Article Snippet: To select the most effective microRNA, the miR-Lepr expressing plasmids were co-transfected with a LepR expression plasmid (Lepr, MR226855, ORIGENE) to HEK293T cells.

Techniques: Injection, Expressing

PYY(3 – 36) and Ex4 in combination increases leptin sensitivity and increases the concentration of circulating soluble leptin receptor. A-D) Accumulated food intake (kcal) and body weight change (g) 4h (A, B) and 20h (C, D) after leptin injection(5 mg/kg) at treatment day 10.E) Plasma leptin concentration (pM) at day 15, F: Plasma concentration of soluble leptin receptor (SLR) at day 15, and G: Hepatic Lepra expression at day 15. Data are expressed as means ± SEM, n = 12. Statistical significance was assessed by one-way ANOVA (E) or by two-way ANOVA followed (F and G). In both cases, ANOVA test's were followed Tukey's multiple comparisons test. In case of A-D, test of significance was restricted to comparing within group effects (vehicle and leptin treatment). *p < 0.05, **p < 0.01, and ***p < 0.001.

Journal: Heliyon

Article Title: Improved leptin sensitivity and increased soluble leptin receptor concentrations may underlie the additive effects of combining PYY [ [1] , [2] , [3] , [4] , [5] , [6] , [7] , [8] , [9] , [10] , [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] , [27] , [28] , [29] , [30] , [31] , [32] , [33] , [34] ] and exendin-4 on body weight lowering in diet-induced obese mice

doi: 10.1016/j.heliyon.2024.e32009

Figure Lengend Snippet: PYY(3 – 36) and Ex4 in combination increases leptin sensitivity and increases the concentration of circulating soluble leptin receptor. A-D) Accumulated food intake (kcal) and body weight change (g) 4h (A, B) and 20h (C, D) after leptin injection(5 mg/kg) at treatment day 10.E) Plasma leptin concentration (pM) at day 15, F: Plasma concentration of soluble leptin receptor (SLR) at day 15, and G: Hepatic Lepra expression at day 15. Data are expressed as means ± SEM, n = 12. Statistical significance was assessed by one-way ANOVA (E) or by two-way ANOVA followed (F and G). In both cases, ANOVA test's were followed Tukey's multiple comparisons test. In case of A-D, test of significance was restricted to comparing within group effects (vehicle and leptin treatment). *p < 0.05, **p < 0.01, and ***p < 0.001.

Article Snippet: Soluble leptin receptor was analysed by a mouse leptin receptor picokine ELISA kit (BOSTER biological technology, Cat # EK0440).

Techniques: Concentration Assay, Injection, Clinical Proteomics, Expressing